Review: Hemostasis Biomarkers

Here is a January 2026 comprehensive review of commonly used and esoteric hemostasis disorder biomarkers in downloadable format: Reardon B, Pasalic L, Favaloro EJ. Biomarkers of coagulation disorders—where to from here? Biomolecules 2026: 16, 235. https://doi.org/10.3390/biom16020235. Abstract Disorders of thrombosis and bleeding contribute to a significant morbidity and mortality burden worldwide. Correctly identifying contributing factors […]

Comments (0)

Global Hemostasis Assays

Feb 4 2026

george

Review: Clot Waveform Analysis

Click this open-access article that reviews attempts at harmonization of clot waveform analysis: Tan JY, De Guzman MRT, Wong WH, et al. Decoding clot waveform analysis: toward better understanding and harmonization. Semin Thromb Hemost. 2026. doi: 10.1055/a-2778-9810. PMID: 41506647. Abstract Clot waveform analysis (CWA) extends routine coagulation assays (activated partial thromboplastin time [PTT] and prothrombin […]

Screening Assays

Thrombophilia Testing After Provoked DVT

Following 2023 ASH guidelines, should facilities proceed with thrombophilia screening for patients who develop VTE following transient triggers? Here is an open-access essay on the effects of the ASH guidelines that appears in the January 1, 2026, issue of Clinical Laboratory News, an ADLM publication. Click “Does Provoked VTE Warrant Thrombophilia Testing?“

Thrombophilia

What is the MRX PT DOAC Assay?

Thanks to Ali Sadeghi-Khomami, PhD, Precision BioLogic Inc., for a heads-up describing the MRX PT DOAC assay, offered by Nordic Biomarker, Umeå and Linköping, Sweden. For details about the assay, obtain this article from your medical library: Salter B, Moffat K, Carlino S, et al. Evaluation of the MRX PT DOAC assay for detection of clinically […]

Comments (0)

Anticoagulant Therapy

Jan 30 2026

george

Review: Neutrophil Extracellular Traps (NETs) in Thrombosis

This open-access review scans literature associating NETs with coagulation: Huang G, Wu H, Lin B, et al. Targeting neutrophil extracellular traps: a new strategy for the treatment of acute ischemic stroke based on thrombolysis resistance. Semin Thromb Hemost. 2026;52:80-91. doi: 10.1055/a-2609-3457. PMID: 40461018; PMCID: PMC12799313. Abstract Acute ischemic stroke (AIS) is a life-threatening thrombotic disorder, […]

Arterial Thrombosis

January 2026 Cheat Sheet

Click here to read our January 2026 Cheat Sheet. The Cheat Sheet introduces and reviews our Quick Questions and presents current developments in hemostasis. If you would like a personal version of the Cheat Sheet featuring links to our January posts, please complete the form on the right. Precision BioLogic Inc. provides free access to […]

Cheat Sheets

February 2026 QQ: DOACs

Our February 2026 Quick Question is a quiz that asks, “Which DOAC is a direct thrombin inhibitor?” Since 2010, DOACs have become our primary antithrombotic agents prescribed for prophylaxis or therapy. While more DOACs are on the horizon, the current anticoagulants directly inhibit either thrombin or FXa. Please make your selection in the right-hand column […]

Comments (0)

Quick Question Archive

Jan 26 2026

george

January 2026 QQ Summary: Fibrinolysis

Our January 2026 QQ was a quiz that asked, “What fibrinolytic enzyme digests fibrin?” Here’s how our 34 respondents scored: D-dimer: 0 Plasmin 28 (82%) PAI-1: 2 (6%) TAFI 0 TPA 4 (12%) Congratulations on your successful answers. Here is a summary of fibrinolysis (figure), paraphrased from Walenga JM, Krum KN. Normal Hemostasis. In Keohane EM, […]

Fibrinolysis

World Thrombosis Day Article: Renal Vein Thrombosis

Click here for a World Thrombosis Day article about Renal Vein Thrombosis. Introduction Renal vein thrombosis is a blood clot that occurs in the veins draining blood from the kidneys. A blood clot in the renal vein will impact kidney function because it slows the flow of blood from the kidney and can reduce the […]

Comments (0)

Anticoagulant Therapy

Jan 24 2026

george

Low-dose Emicizumab Efficacy

Obtain this clinical research article on low-dose emicizumab therapy from your medical library: Datta G, Verma SP, Sinha S, et al. Bridging the Gap: Efficacy of low-dose emicizumab in haemophilia A with or without inhibitors. Haemophilia. 2026. doi: 10.1111/hae.70211. PMID: 41549560. ABSTRACT Introduction Emicizumab has proven to be a turning point in the management of […]

Comments (0)

Bleeding Disorders

All Posts

Review: Hemostasis Biomarkers

Review: Clot Waveform Analysis

Thrombophilia Testing After Provoked DVT

What is the MRX PT DOAC Assay?

Review: Neutrophil Extracellular Traps (NETs) in Thrombosis

January 2026 Cheat Sheet

February 2026 QQ: DOACs

January 2026 QQ Summary: Fibrinolysis

World Thrombosis Day Article: Renal Vein Thrombosis

Low-dose Emicizumab Efficacy

George Fritsma MS MLS

Cheat Sheets from George

Questions or Comments?

Quick Question